6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
5h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
6h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
8h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
15h ago	Buffalo Potash Files Annual Information Form and New Technical Report
16h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

13.05USD+0.75 +6.10%

Closed • Updated at 19:15 GMT+00:00

Market Cap$177.76M

Volume327.0K

Beta0.11

RSI62.54

Health TechnologyPharmaceuticals: Major

Immunic, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

Immunic to Participate in Investor and Medical Conferences in May

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

Community Chat

Ask AI